$PLGO

A Q1 peer roundup in reinsurance highlights results for Everest Group (EG), Pelagos Insurance (PLGO), and RenaissanceRe (RNR). Everest revenue fell to $4.07B (-4.6% YoY) and missed expectations; shares rose 8.4% to $372.96. Pelagos revenue was $610.6M (-7.3%) and beat; shares rose 21.6% to $24.62. RenaissanceRe revenue was $2.19B (-36.8%) and missed; shares rose 4.1% to $323.42.

The article compares Fidelis Insurance (NYSE:PLGO) and Affirmative Insurance (OTCMKTS:AFFM), citing profitability, ownership, valuation, earnings, and analyst views. It says Fidelis has higher revenue and earnings, with 82% institutional ownership. MarketBeat reports PLGO’s consensus price target is $24.33. The article claims Fidelis outperforms on 9 of 9 factors.

On May 26, analysts adjusted price targets across multiple stocks. Royal Bank raised AutoCanada to C$23. JPMorgan cut Array Digital Infrastructure to $54 and Amentum to $31, but raised Analog Devices to $450. Other changes included BofA lifting Ciena to $660 and Cisco to $135, and Stifel trimming CAE to C$47.

Analysts have provided new ratings for several financial companies. Oppenheimer maintained a Buy rating on Gladstone Investment (GAIN) with a $17.00 price target, while Truist Financial maintained a Buy rating on Assurant (AIZ). Goldman Sachs, however, maintained a Sell rating on Pelagos Insurance Capital (PLGO) with an $18.00 price target.

Fidelis Insurance (FIHL) is projected to release its Q1 2026 earnings on Wednesday, May 13th, with analysts forecasting earnings of $0.75 per share and revenue of $903.16 million. The company recently authorized a $400 million share buyback program and paid a quarterly dividend of $0.15, indicating management confidence. Fidelis Insurance previously surpassed EPS estimates but missed revenue targets in the last quarter, and currently holds a "Hold" consensus rating with a target price of $22.64.

Fidelis Insurance Holdings Ltd. shareholders approved a rebrand to Pelagos Insurance Capital Limited, along with governance changes, including the re-election of three Class III directors and the appointment of KPMG as auditor for 2026. The new name and NYSE ticker "PLGO" are expected to be effective in mid-May 2026, aiming to sharpen its capital-focused market positioning. Spark, TipRanks’ AI Analyst, has a "Neutral" rating for FIHL stock, citing mixed financial performance and weak near-term technical momentum, moderated by favorable valuation and positive earnings call commentary.

UBS Group has raised its price target for Fidelis Insurance (NYSE:FIHL) to $25.00 from $24.00, maintaining a "buy" rating and implying a potential 33.44% upside. This follows Fidelis Insurance beating Q4 EPS estimates but missing revenue expectations, along with authorizing a $400 million share buyback program. Despite mixed analyst ratings, the consensus price target for FIHL is $22.36, with the stock currently trading around $18.74.

Fidelis Insurance Holdings Ltd., a Bermuda-based specialty insurer and reinsurer, announced its intention to change its name to Pelagos Insurance Capital Ltd. The rebranding is expected to take effect in May 2026, when the company will also begin trading under the new NYSE ticker symbol, PLGO. Group CEO Dan Burrows explained that "Pelagos," derived from "archipelago," reflects the company's identity as strategic capital allocators and its global community of connected teams and partners.

JPMorgan recently downgraded Fidelis Insurance Holdings (FIHL) from Neutral to Underweight citing concerns about competitive positioning and reliance on the Fidelis Partnership, despite strong Q3 2025 results and divided analyst opinions. Fidelis is set to release its Q4 2025 earnings on February 25, 2026, which will provide new data to assess these concerns. The company's investment narrative is closely tied to short tail specialty and reinsurance markets, and the upcoming earnings report is a key near-term catalyst to clarify competitive risks.

Fidelis Insurance Holdings (FIHL) has experienced a 5.8% increase after reporting strong premium growth of 17.1% annualized over two years and forecasted 10.1% revenue growth for the next 12 months. This growth, coupled with a strengthening capital position and a confirmed dividend of US$0.15 per share, indicates a consolidating competitive position in specialty insurance and reinsurance. While the outlook is positive, investors are cautioned to consider earnings volatility and the reinsurance cycle, especially due to concentrated short-tail catastrophe exposure.